Production (Stage)
Integrated Biopharma, Inc.
INBP
$0.292
$0.0020.69%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 114.39% | 130.37% | 538.98% | 570.00% | 1,681.25% |
| Total Depreciation and Amortization | 0.00% | 5.30% | 7.38% | 6.02% | 1.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 81.69% | 1,488.89% | 208.54% | 20.87% | 69.05% |
| Change in Net Operating Assets | -161.07% | 79.40% | -117.64% | 44.51% | -14.77% |
| Cash from Operations | -62.51% | 111.00% | -49.96% | 84.32% | 11.77% |
| Capital Expenditure | 66.38% | -20.83% | -47.37% | -711.11% | -2,056.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 66.38% | -20.83% | -47.37% | -758.82% | -2,056.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 30.00% | -10.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | 263.64% | -333.33% | -10.00% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -61.18% | 110.20% | -53.52% | 71.72% | -10.80% |